RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand

RISE Life Science Corp. (CSE:RLSC) (the “Company” and/or “RISE”) today announced the launch of its CBD-based wellness brand, Karezza, at retail in California as of June 20, 2018.

Karezza is a suite of sexual wellness supplements that today includes a couples “In the Moment” mood support supplement, plus a “Women’s Daily” supplement and a “Men’s Daily” supplement that supports each gender’s sexual and reproductive body systems.

Each Karezza product contains full-spectrum CBD from organic, U.S. Farm Bill hemp and an FDA-compliant synergistic blend of herbs, adaptogens and essential oils formulated from botanical traditions to enhance sexual experience. These Karezza products are non-psychoactive. The Company plans to expand the suite to include lube and tablet products starting later this summer.

“This launch represents the culmination of four years of R&D,” said Anton Mattadeen, CEO RISE Life Science Corp. “Today, we are officially part of a new era for cannabis and we are excited about being part of the biggest new industry since the technology boom with the development and commercialization of our expanding line of health and wellness products.”

The launch products are available in a highly bio-available oral spray format utilizing “nano” technology, with rapid sublingual absorption and precision dosing to tailor usage for any individual. The suggested MSRP for the supplements is USD$39 each.

Karezza’s launch kicked off yesterday at holistic wellness boutique Mother Nature’s Remedy (MNR), with early response to product on shelves being very positive.

David Slocum, Founder and Owner of MNR said, “It’s exciting and refreshing — different than most products out there. It’s great to see a brand that is really trying to help people move forward using innovative plant-based products so that people can come back to nature.”

Product distribution in California will be supported by Cultivate Kind, which will leverage an existing network of leading retailers already stocking Cultivate Kind’s in-house brand, Life Bloom Organics — a line of hemp-based CBD wellness and sleep aid oral sprays with non-GMO, all natural ingredients.

Furthermore, Cultivate Kind’s sales teams are taking Karezza orders from retail stores, including dispensaries, health food stores, natural grocers and specialty wellness locations, in Los Angeles County and San Francisco County. In addition, products will soon be available via the brand’s e-commerce website.

On June 7, 2018, RISE indicated it had signed a Letter of Intent (LOI) to acquire 100% of Life Bloom Organics, LLC, a California company that produces and markets organic oral sprays containing CBD, and 100% of Cultivate Kind, one of the top marketing and branding agencies for the cannabis industry in the United States.

About RISE Life Science Corp. (riselifescience.com)

RISE Life Science Corp. develops cutting-edge cannabis consumer products for both medical and adult-use markets around the world in jurisdictions that have legal regulatory frameworks in place. All products are based on patent-pending formulations and processes to produce specifically targeted effects. A key area of focus for RISE is research-based formulations to address adult sexual health and wellness for all genders.

About Karezza (karezza.love)

Karezza is the leading brand from RISE Life Science, whose product suite is formulated with CBD and traditional botanicals to support the human body’s systems that improve sexual experiences.

About Cultivate Kind (cultivatekind.com)

Brand strategy agency Cultivate Kind specializes in full-service brand development, go-to-market strategy, and retail marketing. Headquartered in Malibu, California, the executive team specializes in brand pathfinding with an extensive background in consumer product marketing: cannabis brands, food and beverage, wine and spirits, fashion and retail, automotive, and entertainment, all of which inform the company’s best practices and tactical programs for new consumer brands.

About Life Bloom Organics (lifebloomorganics.com)

Life Bloom Organics produces and markets nanotized, hemp-based CBD wellness and sleep aid oral sprays with non-GMO, all natural ingredients. The company is headquartered in Malibu, and all products are formulated and produced in California. Life Bloom Organics products are available for sale online and at retailers throughout southern California.

For Media inquiries, please contact:

Louise Upperton
VP, Marketing and Communications
[email protected]

For Investor inquiries, please contact:

Mark Komonoski
Communication Director
[email protected]


Anton Mattadeen
President & CEO
[email protected]

Cautionary Statement Regarding Forward-Looking Information

The Canadian Securities Exchange has not reviewed this news release and does not accept responsibility for the adequacy or accuracy of this news release.

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in RISE’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, target, goals, projections, anticipated” and similar expressions, are forward- looking statements. Forward-looking statements may include, without limitation, statements including the Company’s expectations with respect to pursuing new opportunities and its future growth and other statements of fact.

Although RISE has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: general economic conditions; pending and proposed legislative or regulatory developments including the impact of changes in laws, regulations and the enforcement thereof; reliance on funding models; operational and infrastructure risks including possible equipment failure and performance of information technology systems; intensifying competition resulting from established competitors and new entrants in the businesses in which the Company operates; insurance coverage of sufficient scope to satisfy any liability claims; fluctuations in total customers; technological change and obsolescence; loss of services of key senior management personnel; privacy laws; leverage and restrictive covenants; fluctuations in cash timing and amount of capital expenditures; tax-related risks; unpredictability and volatility of the price of the Company’s securities; dilution; and future sales of the Company’s securities. Further risks include operational risks of operating in the U.S.; U.S. federal regulation risks; variation in U.S. state regulations; change of U.S. cannabis laws; security risks; risks related to permits and authorizations; risks on liability, enforcement complaints etc.; banking risks; marketing, sales, manufacturing and distribution risk regarding our product growth plans; changes in laws; limited operating history; reliance on management; requirements for additional financing; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change. There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. RISE disclaims any intention or obligation to update or revise such information, except as required by applicable law, and RISE does not assume any liability for disclosure relating to any other company mentioned herein.

Click here to connect with RISE Life Science Corp. (CSE:RLSC) for an Investor Presentation.

The post RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand appeared first on Investing News Network.


Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

Accessibility Tools